Group 1 - The U.S. White House announced that the new tariff measures on pharmaceuticals will not apply to countries that have trade agreements with the U.S. [2][4] - The new tariffs include a 100% tariff on imported brand-name or patented drugs starting October 1, 2025, unless companies establish pharmaceutical manufacturing in the U.S. [4] - Pharmaceutical stocks showed mixed performance in the U.S. market, with Novavax rising by 2.52% and Moderna falling by 0.49% on the day of the announcement [1][2] Group 2 - The U.S. will maintain a 15% tariff cap on pharmaceuticals from trade partners like the EU and Japan, as per existing agreements [2][4] - The U.K. will face a 100% tariff on pharmaceuticals due to ongoing negotiations regarding their trade agreement with the U.S. [2][3] - Canadian steel and related manufacturing industries have seen significant declines in output and exports due to U.S. tariffs, with a 24.8% drop in production since March [5][6]
美国关税政策又有变数！白宫最新发声！
Zheng Quan Shi Bao Wang·2025-09-27 06:07